Aviv REIT Inc (AVIV.N)

AVIV.N on New York Stock Exchange

33.30USD
1:23pm EST
Price Change (% chg)

$0.17 (+0.51%)
Prev Close
$33.13
Open
$33.22
Day's High
$33.32
Day's Low
$33.13
Volume
23,207
Avg. Vol
103,379
52-wk High
$34.70
52-wk Low
$22.74

AVIV.N

Chart for AVIV.N

About

Aviv REIT, Inc. is a self-administered real estate investment trust (REIT) , specializing in the ownership and triple-net leasing of post-acute and long-term cares skilled nursing facilities (SNF). The Company generates its cash rental stream by triple-net leasing its properties to third-party operators , including for all... (more)

Overall

Beta: --
Market Cap (Mil.): $1,943.57
Shares Outstanding (Mil.): 58.66
Dividend: 0.36
Yield (%): 4.35

Financials

  AVIV.N Industry Sector
P/E (TTM): 47.55 44.18 14.90
EPS (TTM): 0.70 -- --
ROI: 3.56 5.87 0.87
ROE: 6.42 10.51 22.58
Search Stocks

Fitch Affirms Omega Healthcare's 'BBB-' IDR Following Aviv Merger Announcement

(The following statement was released by the rating agency) NEW YORK, October 31 (Fitch) Fitch Ratings has affirmed the 'BBB-' Issuer Default Rating (IDR) of Omega Healthcare Investors, Inc. (NYSE: OHI; Omega) and maintained the Rating Outlook at Stable following its announced merger agreement with Aviv REIT, Inc. (NYSE: AVIV), a skilled-nursing-focused peer in an all equity transaction. A full list of rating actions follows at the end of the press release. KEY RATING DRIVERS The affirmati

31 Oct 2014

Omega Healthcare to buy Aviv to boost long-term care business

- Omega Healthcare Investors Inc will buy Aviv REIT Inc for about $2 billion, to take advantage of rising demand for senior-care facilities from an aging U.S. population.

31 Oct 2014

UPDATE 1-Omega Healthcare to buy Aviv to boost long-term care business

Oct 31 - Omega Healthcare Investors Inc will buy Aviv REIT Inc for about $2 billion, to take advantage of rising demand for senior-care facilities from an aging U.S. population.

31 Oct 2014

Omega Healthcare to buy Aviv REIT in $3 bln deal

Oct 31 - Omega Healthcare Investors Inc said it would buy Aviv REIT Inc in a stock deal valued at $3 billion.

31 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks